Financials SKAN Group AG

Equities

SKAN

CH0013396012

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange 11:31:30 2024-04-26 am EDT 5-day change 1st Jan Change
82 CHF +0.61% Intraday chart for SKAN Group AG +5.13% +1.49%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 1,992 1,416 1,817 1,844 - -
Enterprise Value (EV) 1 1,876 1,322 1,817 1,722 1,711 1,844
P/E ratio 105 x 75 x 69.1 x 45.4 x 33.9 x -
Yield 0.27% 0.4% - 0.73% 1% -
Capitalization / Revenue 8.5 x 5.11 x 5.68 x 4.73 x 3.99 x 3.71 x
EV / Revenue 8.01 x 4.77 x 5.68 x 4.42 x 3.71 x 3.71 x
EV / EBITDA 61.1 x 32.9 x 36.2 x 27.9 x 21 x -
EV / FCF -65.3 x 37.4 x - 168 x 79 x 30.7 x
FCF Yield -1.53% 2.67% - 0.6% 1.27% 3.25%
Price to Book 12.5 x 9 x - 8.71 x 6.91 x -
Nbr of stocks (in thousands) 22,484 22,484 22,484 22,484 - -
Reference price 2 88.60 63.00 80.80 82.00 82.00 82.00
Announcement Date 4/5/22 3/28/23 3/26/24 - - -
1CHF in Million2CHF
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 234.3 277 320 389.8 461.7 497.3
EBITDA 1 30.68 40.15 50.14 61.8 81.37 -
EBIT 1 23.06 29.46 37.75 48.4 65.47 76.1
Operating Margin 9.84% 10.64% 11.8% 12.42% 14.18% 15.3%
Earnings before Tax (EBT) 1 24.73 25.24 32.79 50.3 68.77 -
Net income 1 21.4 18.99 26.31 40.6 54.47 -
Net margin 9.13% 6.86% 8.22% 10.41% 11.8% -
EPS 2 0.8400 0.8400 1.170 1.805 2.420 -
Free Cash Flow 1 -28.7 35.35 - 10.27 21.67 60
FCF margin -12.25% 12.77% - 2.63% 4.69% 12.07%
FCF Conversion (EBITDA) - 88.05% - 16.61% 26.63% -
FCF Conversion (Net income) - 186.21% - 25.29% 39.78% -
Dividend per Share 2 0.2400 0.2500 - 0.6000 0.8200 -
Announcement Date 4/5/22 3/28/23 3/26/24 - - -
1CHF in Million2CHF
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 S1 2023 S1
Net sales 1 120.9 139.7
EBITDA 1 10.68 18.6
EBIT 1 - 12.4
Operating Margin - 8.87%
Earnings before Tax (EBT) 1 - 10.24
Net income 1 - 7.804
Net margin - 5.58%
EPS - -
Dividend per Share - -
Announcement Date 8/23/22 8/22/23
1CHF in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - -
Net Cash position 1 116 94.1 - 122 132 -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -28.7 35.4 - 10.3 21.7 60
ROE (net income / shareholders' equity) 10.5% - - - - -
ROA (Net income/ Total Assets) 3.59% - - - - -
Assets 1 596.1 - - - - -
Book Value Per Share 2 7.100 7.000 - 9.410 11.90 -
Cash Flow per Share 2 0.8200 2.730 - 2.050 2.950 -
Capex 1 39 26.1 - 34.3 50.7 30.7
Capex / Sales 16.66% 9.43% - 8.8% 10.97% 6.17%
Announcement Date 4/5/22 3/28/23 3/26/24 - - -
1CHF in Million2CHF
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
82 CHF
Average target price
91.33 CHF
Spread / Average Target
+11.38%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SKAN Stock
  4. Financials SKAN Group AG